Moreover, the tumor volumes in the HL60/TβRII-B group were significantly lower than in the HL60/TβRII and HL60/NEO group 22 days after inoculation (P < 0.05) (Figure 3). This evidence concerns the gene TGFBR2 and neoplasm.